MoneyWorks4Me

Hikal - Quaterly Results

14 May 2025 Evaluate
The company witnessed a 7.45% growth in the revenue at Rs. 5524.00 millions for the quarter ended March 2025 as compared to Rs. 5141.00 millions during the year-ago period.Net Profit recorded in the quarter ended March 2025 rise to 48.82% to Rs. 503.00  millions  compared to R. 338.00 millions in corresponding previous quarter.Operating Profit saw a handsome growth to 1240.00 millions from 948.00 millions in the quarter ended March 2025.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 5524.00 5141.00 7.45 18598.00 17846.00 4.21 18598.00 17846.00 4.21
Other Income 5.00 5.00 0.00 50.00 25.00 100.00 50.00 25.00 100.00
PBIDT 1240.00 948.00 30.80 3335.00 2694.00 23.79 3335.00 2694.00 23.79
Interest 179.00 153.00 16.99 752.00 564.00 33.33 752.00 564.00 33.33
PBDT 1061.00 795.00 33.46 2583.00 2130.00 21.27 2583.00 2130.00 21.27
Depreciation 377.00 323.00 16.72 1344.00 1176.00 14.29 1344.00 1176.00 14.29
PBT 684.00 472.00 44.92 1239.00 954.00 29.87 1239.00 954.00 29.87
TAX 181.00 134.00 35.07 330.00 259.00 27.41 330.00 259.00 27.41
Deferred Tax 8.00 -26.00 -130.77 30.00 -25.00 -220.00 30.00 -25.00 -220.00
PAT 503.00 338.00 48.82 909.00 695.00 30.79 909.00 695.00 30.79
Equity 247.00 247.00 0.00 247.00 247.00 0.00 247.00 247.00 0.00
PBIDTM(%) 22.45 18.44 21.73 17.93 15.10 18.79 17.93 15.10 18.79
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..